Form 8-K - Current report:
SEC Accession No. 0001493152-24-017745
Filing Date
2024-05-03
Accepted
2024-05-03 17:00:17
Documents
16
Period of Report
2024-05-03
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49775
2 ex16-1.htm EX-16.1 8774
3 ex16-1_001.jpg GRAPHIC 4269
4 ex16-1_002.jpg GRAPHIC 6003
  Complete submission text file 0001493152-24-017745.txt   245897

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE rnxt-20240503.xsd EX-101.SCH 3015
6 XBRL LABEL FILE rnxt-20240503_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE rnxt-20240503_pre.xml EX-101.PRE 22359
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3461
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

EIN.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40738 | Film No.: 24914177
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)